The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geng, L.
Right arrow Articles by Rudd, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geng, L.
Right arrow Articles by Rudd, C. E.
The Journal of Immunology, 1999, 163: 5753-5757.
Copyright © 1999 by The American Association of Immunologists

CUTTING EDGE

Cutting Edge: SLP-76 Cooperativity with FYB/FYN-T in the Up-Regulation of TCR-Driven IL-2 Transcription Requires SLP-76 Binding to FYB at Tyr595 and Tyr651

Liping Geng*,{dagger}, Monika Raab*,{ddagger} and Christopher E. Rudd1,*,{dagger},{ddagger}

* Division of Tumor Immunology, Department of Cancer Immunology and AIDS, {dagger} Dana Farber Cancer Institute and Departments of Medicine and {ddagger} Pathology, Harvard Medical School, Boston, MA 02115


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results and Discussion
 References
 
SLP-76 (Src homology (SH) 2-domain-containing leukocyte protein of 76 kDa) and FYB/SLAP (FYN-T-binding protein/SLP-76-associated protein) are two hemopoietic cell-specific adaptor proteins downstream of TCR-activated protein tyrosine kinases. SLP-76 has been implicated as an essential component in T cell signaling. FYB is selectively phosphorylated by FYN-T, providing a template for the recruitment of FYN-T and SLP-76 SH2 domains. Coexpression of FYN-T, FYB, and SLP-76 can synergistically up-regulate IL-2 production in T cells upon TCR ligation. In this report, we show that two tyrosines, Tyr595 and Tyr651, of FYB are major sites of phosphorylation by FYN-T and mediate binding to SLP-76 in Jurkat T cells. Furthermore, the synergistic up-regulation of IL-2 promoter activity in the FYN-T-FYB-SLP-76 pathway is contingent upon the interaction between FYB and SLP-76, but not the interaction between FYB and FYN-T. These observations define a pathway by which SLP-76 interacts with downstream components in the up-regulation of T cell cytokine production.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results and Discussion
 References
 
Engagement of the TCR by peptide/MHC complexes results in the activation of a number of protein-tyrosine kinases (1, 2, 3), including members of the src family, LCK and FYN-T, and syk family, ZAP-70 and SYK. Activated protein-tyrosine kinases can then phosphorylate a variety of substrates that act as adaptor proteins to activate other signaling pathways, including the phosphatidylinositol and Ras/extracellular signal-related kinase second messenger pathways, leading to T cell proliferation and cytokine production.

Among the substrates identified are the hemopoietic cell-specific adaptor proteins, SLP-76 (Src homology (SH) 2-domain-containing leukocyte protein of 76 kDa)2 and FYB/SLAP (Fyn T-binding protein/SLP-76-associated protein) (4, 5, 6). SLP-76 is an adaptor protein that is comprised of three domains allowing for protein-protein interactions: an amino-terminal acidic region containing tyrosine phosphorylation sites (7), a central proline-rich region that binds to the SH3 domain of Grb2 family members (8, 9), and a carboxyl-terminal SH2 domain that associates with FYB/SLAP (5, 6). The importance of SLP-76 in T cell signaling has been demonstrated in experiments in the Jurkat human T cell leukemia line and in SLP-76-deficient mice. SLP-76 overexpression in Jurkat cells augments TCR-mediated activation of the IL-2 promoter (9, 10). Furthermore, Jurkat T cells lacking SLP-76 show defects in TCR-mediated signals (11). Studies of SLP-76-/- mice also indicate that SLP-76 is required for pre-TCR signaling, as these mice exhibit arrest of thymocyte development at the double negative CD25+ CD44- stage (12, 13).

FYB/SLAP was independently cloned on the basis of its ability to bind to the src kinase FYN-T and SLP-76 (5, 6). It also has the hallmarks of an adaptor protein with several proline-rich regions, two putative nuclear localization sequences, a carboxyl-terminal SH3 domain, and multiple tyrosine-containing motifs. Two forms of FYB at 120 and 130 kDa exits that differ due to an insertion of 46 aa toward the C terminus (14). FYB-120 corresponds to the version of SLAP termed SLAP-130 (5). FYB undergoes tyrosine phosphorylation in response to TCR ligation, an event diminished in FYN-T-deficient T cells (15). However, unlike with SLP-76, transfection studies with FYB/SLAP have yielded conflicting results on the role of FYB/SLAP in the regulation of IL-2 production. Recent studies from our laboratory demonstrated that FYB is selectively phosphorylated between residue 585 and 670 by FYN-T (16), providing a template for the recruitment of the SH2 domains of FYN-T and SLP-76. The interaction between FYN-T, FYB, and SLP-76 is unusual in its distinct cytoplasmic localization and its stable kinetics of phosphorylation. Furthermore, coexpression of all three components of the FYN-T-FYB-SLP-76 matrix can cooperatively up-regulate anti-CD3-mediated IL-2 transcription in Jurkat T cells (16). However, previous studies have not addressed whether direct association between these components is required for their synergy.

In this paper, we demonstrate that two YDDV sites on FYB are major sites of phosphorylation by FYN-T and serve as major sites for SLP-76 SH2 domain binding. We further demonstrate that the loss of SLP-76 binding by mutation of these sites markedly reduced the ability of FYN-T-FYB-SLP-76 to up-regulate IL-2 transcription. By contrast, mutation of the FYN-T SH2 domain binding site had no consistent effect. Overall, these results indicate a role for SLP-76/FYB complex formation in the regulation of TCR-driven IL-2 production.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results and Discussion
 References
 
Abs

Monoclonal Ab to SLP-76 was kindly provided by Dr. Paul R. Findell (Syntex, Palo Alto, CA). Anti-phosphotyrosine mAb 4G10 was kindly provided by Dr. Tom Roberts (Dana-Farber Cancer Institute, Boston, MA). Anti-human CD3 (OKT3) was obtained from American Type Culture Collection (Manassas, VA).

DNA constructs

Wild-type FYB were cloned into the EcoRI and SalI sites of pSR{alpha} mammalian expression vector containing a sequence encoding the influenza hemaaglutinin (HA) epitope tag at the N terminal. The FYB deletion mutations have been described. The tyrosine mutants were created with the Quickchange Mutagenesis kit (Stratagene, La Jolla, CA) using oligonucleotides (Life Technologies, Gaithersburg, MD) encoding the appropriate mutations plus silent mutations to provide novel restriction sites for diagnosis. The NF-AT luciferase reporter construct was provided by Dr. Burakoff (Dana-Farber Cancer Institute).

Transfections, immunoprecipitation, and immunoblotting

Transfections and immunoprecipitations were conducted as previously described (17, 18). Briefly, 20 x 106 SV40 large tumor Ag-transfected Jurkat cells were electroporated and allowed to sit for 20 h. Cells were harvested and lysed with 200 µl lysis buffer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% (v/v) Triton X-100, 1 mM sodium vanadate, 1 mM PMSF, 1 mM leupeptin). Immunoprecipitation was conducted by incubation of the lysate with the Ab for 1 h at 4°C, followed by incubation with 50 µl of protein A-Sepharose beads (10% w/v) for 1 h at 4°C. Immunoprecipitates were washed three times with ice-cold lysis buffer and subjected to SDS-PAGE. For immunoblotting, the immunoprecipitates were separated by SDS-PAGE and transferred onto nitrocellulose filters (Schleicher and Schuell, Keene, NH). Filters were blocked with 5% (w/v) skim milk for 1 h in TBS, pH 8.0, and then probed with the indicated Ab. Bound Ab was revealed with HRP-conjugated rabbit anti-mouse or donkey anti-rabbit Abs using enhanced chemiluminescence (Amersham, Arlington Heights, IL).

Luciferase assays

A total of 5 x 105 transfected Jurkat cells were stimulated with 1 µg/ml OKT3 and 2 µg/ml rabbit anti-mouse Ab at 37°C for 6 h and subsequently assayed for luciferase activity following manufacturer suggested protocols (dual luciferase system kit; Promega, Madison, WI). Luciferase activity was determined using the luminometer (MicroLumat, EG&G Berthold Bad WildBad, Germany). Luciferase units of the experimental vector were normalized to the level of the control vector in each sample.


   Results and Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
References
 
Tyrosines 595 and 651 are major phosphorylation sites by FYN-T

Recent studies in our laboratory demonstrated that the region between residues 585 and 670 on FYB was selectively phosphorylated by FYN-T, but not LCK and ZAP-70, and mediates binding to SH2 domains of FYN-T and SLP-76 (16). Fig. 1GoA shows the amino acid sequence of a portion of this region highlighting the three potential tyrosine phosphorylation motifs that would be suited for SH2 domain binding (YDDV, residues 595–598; YDGI, residues 625–628; YDDV, residues 651–654). The YDGI site has previously been identified as the predominant FYN-T-binding site in vitro by peptide binding assays and in vivo using mutant FYB in which the tyrosine of the YDGI site was replaced by phenylalanine (16). The two Y595DDV and Y651DDV motifs are similar, each containing conserved EV residues preceding the YDDV sequence (Fig. 1GoA). By in vitro peptide binding assay, the C-terminal YDDV motif was shown to be able to bind to SLP-76 SH2 domain (16). However, in vivo studies are necessary to confirm this result and to test whether the N-terminal YDDV motif or other tyrosine-containing motifs in FYB can bind to SLP-76 as well.



View larger version (31K):
[in this window]
[in a new window]
  		FIGURE 1. Tyrosines 595 and 651 are phosphorylated by FYN-T in Jurkat cells. A, The wild-type amino acid sequence (single letter code) of a portion of the carboxyl-terminal region of FYB is shown (WT). Two exact 6-aa repeats and a third tyrosine-containing motif responsible for binding to FYN-T are indicated in bold and underlined. Also shown are the variants of FYB created for these studies with phenylalanine (F) replacing tyrosines (Y) in the highlighted region. B, cDNA-encoding HA-tagged FYB (lanes 1 and 2) and FYB mutants (lanes 3–5) were transfected alone (lane 1) or cotransfected with FYN-T (lanes 2–5) into Jurkat cells. Then, 20 h after transfection, lysates were prepared in 1% Triton X-100 lysis buffer, subjected to SDS-PAGE, and immunoblotted with anti-pTyr Ab (upper panel) or anti-HA Ab (lower panel). Positions of molecular mass markers (kDa) are indicated. C, Densitometric analysis using the Scantjet laser scanner (Hewlett-Packard) of anti-pTyr binding to FYB (A, upper panel). Values were standardized with anti-HA binding to FYB (A, lower panel).

 
To address this, mutant human FYB-120 cDNA constructs encoding substitutions at one or both tyrosines of the YDDV motifs with FDDV were generated (Fig. 1GoA). Each construct included an epitope tag (HA) for detection of the transfected molecule. The FYB-120 isoform was used in this study and is referred to as FYB in the rest of the paper. To determine whether the YDDV motifs are sites of FYN-T phosphorylation, wild-type FYB (WT FYB) and FYB mutants were coexpressed with FYN-T in Jurkat T cells and were assessed for phosphorylation by anti-phosphotyrosine blotting (Fig. 1GoB, upper panel). As previously reported, WT FYB was tyrosine-phosphorylated by FYN-T (lane 2 vs 1). The Y595F and Y651F single mutants were significantly less phosphorylated when compared with WT FYB (lane 3 and 4 vs 2). Phosphorylation was reduced even further (generally <30% of WT) in the Y595/651F double mutant (lane 5; also see histogram in Fig. 1GoC). As an internal control for expression, anti-HA Ab detected similar levels of expression for FYB and the mutants (Fig. 1GoB, lower panel). These data demonstrate that Y595 and Y651 are major sites of phosphorylation by FYN-T. Much longer exposure revealed a slight FYB band in lane 1 (Fig. 1GoB), indicating a basal level of FYB phosphorylation in resting Jurkat, as previously reported in other studies (5, 15). The remaining 30% phosphorylation in the Y595/651F double mutant can be explained by protein tyrosine kinase phosphorylation of other tyrosines in the sequence of FYB, in particular Y625 of the YDGI motif that has been demonstrated to mediate direct binding to FYN-T (16).

Both YDDV sites are necessary for optimal SLP-76 binding

To assess whether the two pYDDV sites are responsible for binding to SLP-76, the three FYB mutants (Y595F, Y651F, and Y595/651F) were coexpressed with FYN-T and HA-tagged SLP-76 in Jurkat T cells followed by immunoprecipitation with anti-SLP-76 mAb and anti-HA blotting. The expression levels of FYB and the mutants and SLP-76 were similar as shown in the whole-cell lysates (Fig. 2GoA, right upper and lower panels, respectively). As expected, SLP-76 coprecipitated WT FYB (left panel, lane 1), whereas the double mutant Y595/651F fail to coprecipitate with SLP-76. The single mutations resulted in significant reductions in SLP-76 binding, with Y651F having a greater effect (55% reduction) than Y595F (20% reduction) (left panel, lanes 2 and 3; also see Fig. 2GoB: densiometric readings in histogram).



View larger version (24K):
[in this window]
[in a new window]
  		FIGURE 2. Tyrosine 595 and tyrosine 651 cooperatively bind to SLP-76. A, Jurkat cells were transfected with FYN-T, HA-tagged SLP-76, and HA-tagged FYB or FYB mutants. Then, 20 h after transfection, cells were lysed and precipitated with anti-SLP-76 Ab. Cell lysates (lanes 5–8) and anti-SLP-76 immunocomplexes (lanes 1–4) were subjected to SDS-PAGE and blotted with anti-HA. Positions of molecular mass markers (kDa) are indicated. Lanes 1 and 5, cells transfected with WT FYB; lanes 2 and 6, Y595F; lanes 3 and 7, Y651F; lanes 4 and 8, Y595/651F. B, Densitometric analysis using the Scantjet laser scanner (Hewlett-Packard) of FYB bound to SLP-76 (A, left panel).

 
From these observations, it appears that in T cells both Tyr595 and Tyr651 are essential for optimal binding of SLP-76. Both Tyr595 and Tyr651 are found in similar sequence motifs (EVYDDV), either of which would be predicted to bind the SLP-76 SH2 domain. Indeed, we previously showed that a phosphorylated peptide corresponding to the C-terminal EVpYDDV motif precipitated SLP-76 from cell lysates (16). The involvement of two sites is reminiscent of the interaction between SLP-76 and the VAV SH2 domain, where both DYESP motifs are required for VAV SH2 domain binding to SLP-76 (17, 19). Although the basis for this observation is not clear, it may simply be related to the fact that both sites are used for SLP-76 binding, perhaps with Y651F being the preferred site.

FYB and SLP-76 interaction is required to up-regulate NF-AT activity in the FYN-T-FYB-SLP-76 pathway

To address the role of SLP-76 binding to FYB in T cell function, Jurkat T cells were transiently transfected with FYB mutants or a control SR{alpha} vector together with FYN-T and SLP-76 and a luciferase reporter construct driven by an IL-2 NF-AT/AP-1 promoter. The mutants used include the YDDV mutants, a C-terminal deletion mutant D585 (deletion from amino acid 585 to C terminus), and a FYB mutant with the Tyr625 in the YDGI motif substituted by phenylalanine (Y625F). This latter site has previously been shown to bind to FYN-T, but had not been examined for an effect on IL-2 transcription (16). As reported, the combined expression of FYN-T/FYB/SLP-76 potentiated IL-2 transcription by about 100-fold beyond vector-transfected control (Fig. 3Go, A and B). Deletion mutant D585, which lacks the region of FYN-T and SLP-76 binding, effectively eliminated the potentiating effect (Fig. 3GoA, left panel). By contrast, the Y625F mutant had little effect on FYB synergy with FYN and SLP-76 (left panel). Several experiments showed no efect, while a slight degree of inhibition. This result can be explained by two scenarios. One possibility is that FYN-T complex formation with FYB and SLP-76 is not necessary for the FYB-FYN-SLP-76 pathway. FYN-T may only be required to phosphorylate FYB, which can then be accessed by a third anchor protein such as SLP-76. Alternatively, the Y625F mutant retains some 20% WT FYB binding to FYN-T, indicating a site other than YDGI can mediate the FYB-FYN-T interaction, albeit much less efficiently. This limited interaction may be sufficient to mediate the up-regulation of TCR-stimulated NF-AT/AP-1 activity



View larger version (27K):
[in this window]
[in a new window]
  		FIGURE 3. FYB and SLP-76 association is required for the optimal up-regulation of NF-AT/AP-1 promoter activity in the FYN-T-FYB-SLP-76 pathway. A total of 2 x 107 Jurkat T cells were subjected to electroporation using 5 µg IL-2, 3x NF-AT luciferase reporter plasmid, and 0.2 µg RL-TK control plasmid together with various combinations of 20 µg each of FYB or FYB mutants, FYN-T, SLP-76. Empty vector was used to make the amount of DNA equal in each sample. Cells were either stimulated with rabbit anti-mouse IgG (2 µg/ml) alone ({square}) or in combination with OKT3 (1 µg/ml) () for 6 h and assayed for luciferase activity. Luciferase units of the experimental vector were normalized to the level of the control plasmid in each sample. The data are representative of at least five independent experiments. A, FYB and FYN association is not required for the optimal up-regulation of NF-AT/AP-1 promoter activity in the FYN-T-FYB-SLP-76 pathway. D585, C-terminal deletion mutants of FYB. Y625F, mutant FYB bearing Y->FDGI mutation shown unable to bind to FYN. B, FYB and SLP-76 association are required to up-regulate NF-AT activity in the FYN-T-FYB-SLP-76 pathway. Y595F, Y651F, and Y595/651F, FYB mutants with Y->FDDV mutations.

 
Analysis of the single and double YDDV mutants indicate that FYB-SLP-76 interaction is crucial in the FYN-T-FYB-SLP-76 pathway, as a marked reduction of NF-AT/AP-1 activity was observed in transfectants expressing the mutants compared with the WT FYB (Fig. 3GoA, right panel). The reduction was greatest with the Y651F single mutant and the double Y595/651F mutant, reducing the NF-AT activity by 50–70% compared with the wild type (Fig. 3GoB and data not shown). The different effect of the two single mutants correlates with the differences in the relative importance of each site for SLP-76 binding (Fig. 2GoB, lower left panel), further confirming the functional importance of the two sites. Indeed, often the effect of the single Y651 site was found as effective as Y595/651F mutant in reducing IL-2 transcription. In several other experiments, the reduction mediated by the Y651 was midway between the Y595F and Y595/651F double mutant. In both cases, these data confirm the importance of the SLP-76 binding to the FYB scaffold at sites Y595/651F in the optimal up-regulation of TCR-driven IL-2 production.

Recent studies have demonstrated that the importance of the SLP-76 (and LAT) adaptors in T cell signaling (9, 10, 11, 17, 20, 21, 22). Further, the combined expression of SLP-76 with the FYB adaptor and FYN-T has demonstrated potent increases in TCR-driven IL-2 production (14, 16). Whether this cooperativity was related to separate effects of each component on different pathways or was genuinely related to binding between the components had been unclear. Our mapping of the SLP-76 binding sites and our finding that binding is needed for the potentiation of IL-2 transcription demonstrates that FYB’s role as a scaffold for SLP-76 binding contributes to optimal activation. The functional significance of the FYB-SLP-76 interaction in SLP-76 function is also consistent with the report that the SLP-76 SH2 domain is needed for its ability to augment IL-2 transcription (9). FYB/SLAP is the principal protein that has been found to bind to the SLP-76 SH2 domain (5, 15). The residual stimulatory effects of the Y595/651F double mutant further argue that other signaling components (albeit less potent than SLP-76) can also use other sites on the FYB scaffold in the mediation of signals leading to IL-2 transcription (Fig. 3GoB). We are now in the process of determining the identity of the second messenger pathways downstream of the interaction.


   Footnotes
 
1 Address correspondence and reprint requests to Dr. Christopher E. Rudd, Division of Tumor Immunology, Dana Farber Cancer Institute 1540, 44 Binney Street, D520, Boston, MA 02115. E-mail address: Back

2 Abbreviations used in this paper: SLP-76, SH2-domain-containing leukocyte protein of 76 kDa; SH, Src homology; FYB, Fyn T-binding protein; SLAP, SLP-76-associated protein; HA, hemagglutinin. Back

Received for publication September 13, 1999. Accepted for publication September 29, 1999.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 

  1. Rudd, C. E., O. Janssen, Y.-C. Cai, A. J. da Silva, M. Raab, K. V. S. Prasad. 1994. Two-step TCR{zeta}/CD3 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinases. Immunol. Today 15:225.[Medline]
  2. Wange, R. L., L. E. Samelson. 1996. Complex complexes: signaling at the TcR. Immunity 5:197.[Medline]
  3. Weiss, A., D. R. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell 76:263.[Medline]
  4. Jackman, J. K., D. G. Motto, Q. Sun, M. Tanemoto, C. W. Turck, G. A. Peltz, G. A. Koretzky, P. R. Findell. 1995. Molecular cloning of SLP-76, a 76-kDa tyrosine phosphoprotein associated with Grb2 in T cells. J. Biol. Chem. 270:7029.[Abstract/Free Full Text]
  5. Musci, M. A., L. R. Hendricks-Taylor, D. G. Motto, M. Paskind, J. Kamens, C. W. Turck, G. A. Koretzky. 1997. Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases. J. Biol. Chem. 272:11674.[Abstract/Free Full Text]
  6. da Silva, A. J., Z. Li, C. de Vera, E. Canto, P. Findell, C. E. Rudd. 1997. Cloning of a novel T-cell protein FYB that binds FYN and SH2-domain-containing leukocyte protein 76 and modulate interleukin 2 production. Proc. Natl. Acad. Sci. USA 94:7493.[Abstract/Free Full Text]
  7. Fang, N., D. G. Motto, S. E. Ross, G. A. Koretzky. 1996. Tyrosine 113, 128, and 145 of SLP-76 are required for optimal augmentation of NFAT promoter activity. J. Immunol. 157:3769.[Abstract]
  8. Liu, S. K., N. Fang, D. Bouchard, G. A. Koretzky, C. J. McGlade. 1999. The hematopoietic-specific adaptor protein, Gads functions in T-cell receptor signaling through interactions with SLP-76 and LAT. Curr. Biol. 9:67.[Medline]
  9. Motto, D. G., S. E. Ross, J. Wu, L. R. Hendriks-Taylor, G. A. Koretzky. 1996. Implications of the GRB2-associated phosphoprotein SLP-76 in T cell receptor-mediated Interleukin 2 production. J. Exp. Med. 183:1937.[Abstract/Free Full Text]
  10. Wardenburg, J. B., C. Fu, J. K. Jackman, H. Flotow, S. E. Wilkinson, D. H. Williams, R. Johnson, G. Kong, A. C. Chan, P. R. Findell. 1996. Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell receptor function. J. Biol. Chem. 271:19641.[Abstract/Free Full Text]
  11. Yablonski, D., M. R. Kuhne, T. Kadlecek, A. Weiss. 1998. Uncoupling of nonreceptor tyrosine kinases from PLC-{gamma}1 in a SLP-76-deficient T cell. Science 218:413.
  12. Clements, J. L., B. Yang, S. E. Ross-Barta, S. L. Eliason, R. F. Hirstka, R. A. Williamson, G. A. Koretzky. 1998. Requirement for the leucocyte-specific adapter protein SLP-76 for normal T cell development. Science 281:416.[Abstract/Free Full Text]
  13. Pivniouk, V., E. Tsitsikov, P. Swinton, G. Rathbun, F. W. Alt, R. S. Geha. 1998. Impaired viability and profound block in thymocyte development in mice lacking the adaptor protein SLP-76. Cell 94:229.[Medline]
  14. Veale, M., M. Raab, Z. Li, A. da Silva, S.-K. Kaeft, S. Weremowicz, C. C. Morton, C. E. Rudd. 1999. Novel isoform of lymphoid adaptor FYN-T-binding protein (FYB-130) interacts with SLP-76 and up-regulates interleukin 2 production. J. Biol. Chem. 274:31170.
  15. da Silva, A. J., J. M. Rosenfield, I. Mueller, A. Bouton, H. Hirai, C. E. Rudd. 1997. Biochemical analysis of p120/130: a protein-tyrosine kinase substrate restricted to T and myeloid cells. J. Immunol. 158:2007.[Abstract]
  16. Raab, M., H. Kang, A. da Silva, X. Zhu, C. E. Rudd. 1999. FYN-T-FYB-SLP-76 interactions define a T-cell receptor {zeta}/CD3-mediated tyrosine phosphorylation pathway that up-regulates interleukin 2 transcription in T-cells. J. Biol. Chem. 274:21170.[Abstract/Free Full Text]
  17. Raab, M., A. J. da Silva, P. R. Findell, C. E. Rudd. 1997. Regulation of Vav-SLP-76 binding by ZAP-70 and its relevance to TcR{zeta}/CD3 induction of interleukin 2. Immunity 6:1.[Medline]
  18. Raab, M., C. E. Rudd. 1996. Hematopoietic cell phosphatase (HCP) regulates p56lck phosphorylation and ZAP-70 binding to T cell receptor {zeta} chain. Biochem. Biophys. Res. Commun. 222:50.[Medline]
  19. Fang, N., G. A. Koretzky. 1999. SLP-76 and Vav function in separate, but overlapping pathways to augment interleukin-2 promoter activity. J. Biol. Chem. 274:16206.[Abstract/Free Full Text]
  20. Finco, T. S., T. Kadlecek, W. Zhang, L. E. Samelson, A. Weiss. 1998. LAT is required for TCR-mediated activation of PLC{gamma}1 and the Ras pathway. Immunity 9:617.[Medline]
  21. Zhang, W. J., J. Sloan-Lancaster, J. Kitchen, R. P. Trible, L. E. Samelson. 1998. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 92:83.[Medline]
  22. Rodd, C. E.. 1999. Adaptors and molecular scaffolds in immune cell signaling. Cell 96:5.[Medline]



This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Wang, B. Wei, G. Bismuth, and C. E. Rudd
SLP-76-ADAP adaptor module regulates LFA-1 mediated costimulation and T cell motility
PNAS, July 28, 2009; 106(30): 12436 - 12441.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. J. Burbach, R. Srivastava, R. B. Medeiros, W. E. O'Gorman, E. J. Peterson, and Y. Shimizu
Distinct Regulation of Integrin-Dependent T Cell Conjugate Formation and NF-{kappa}B Activation by the Adapter Protein ADAP
J. Immunol., October 1, 2008; 181(7): 4840 - 4851.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Abudula, A. Grabbe, M. Brechmann, C. Polaschegg, N. Herrmann, I. Goldbeck, K. Dittmann, and J. Wienands
SLP-65 Signal Transduction Requires Src Homology 2 domain-mediated Membrane Anchoring and a Kinase-independent Adaptor Function of Syk
J. Biol. Chem., September 28, 2007; 282(39): 29059 - 29066.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Kasirer-Friede, B. Moran, J. Nagrampa-Orje, K. Swanson, Z. M. Ruggeri, B. Schraven, B. G. Neel, G. Koretzky, and S. J. Shattil
ADAP is required for normal {alpha}IIb{beta}3 activation by VWF/GP Ib-IX-V and other agonists
Blood, February 1, 2007; 109(3): 1018 - 1025.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J.-i. Suzuki, S. Yamasaki, J. Wu, G. A. Koretzky, and T. Saito
The actin cloud induced by LFA-1-mediated outside-in signals lowers the threshold for T-cell activation
Blood, January 1, 2007; 109(1): 168 - 175.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
S. Kliche, D. Breitling, M. Togni, R. Pusch, K. Heuer, X. Wang, C. Freund, A. Kasirer-Friede, G. Menasche, G. A. Koretzky, et al.
The ADAP/SKAP55 Signaling Module Regulates T-Cell Receptor-Mediated Integrin Activation through Plasma Membrane Targeting of Rap1.
Mol. Cell. Biol., October 1, 2006; 26(19): 7130 - 7144.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. N. Wu, S. Gheith, N. A. Bezman, Q.-H. Liu, L. V. Fostel, A. M. Swanson, B. D. Freedman, G. A. Koretzky, and E. J. Peterson
Adhesion- and Degranulation-Promoting Adapter Protein Is Required for Efficient Thymocyte Development and Selection.
J. Immunol., June 1, 2006; 176(11): 6681 - 6689.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. S. Duke-Cohan, H. Kang, H. Liu, and C. E. Rudd
Regulation and Function of SKAP-55 Non-canonical Motif Binding to the SH3c Domain of Adhesion and Degranulation-promoting Adaptor Protein
J. Biol. Chem., May 12, 2006; 281(19): 13743 - 13750.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Koga, K. Yogo, K. Yoshikawa, H. Samori, M. Goto, T. Uchida, N. Ishida, and T. Takeya
Physical and Functional Association of c-Src and Adhesion and Degranulation Promoting Adaptor Protein (ADAP) in Osteoclastogenesis in Vitro
J. Biol. Chem., September 9, 2005; 280(36): 31564 - 31571.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Huang, D. D. Norton, P. Precht, J. L. Martindale, J. K. Burkhardt, and R. L. Wange
Deficiency of ADAP/Fyb/SLAP-130 Destabilizes SKAP55 in Jurkat T Cells
J. Biol. Chem., June 24, 2005; 280(25): 23576 - 23583.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
H. Wang, F. E. McCann, J. D. Gordan, X. Wu, M. Raab, T. H. Malik, D. M. Davis, and C. E. Rudd
ADAP-SLP-76 Binding Differentially Regulates Supramolecular Activation Cluster (SMAC) Formation Relative to T Cell-APC Conjugation
J. Exp. Med., October 18, 2004; 200(8): 1063 - 1074.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
S. Tsuji, M. Okamoto, K. Yamada, N. Okamoto, R. Goitsuka, R. Arnold, F. Kiefer, and D. Kitamura
B Cell Adaptor Containing Src Homology 2 Domain (Bash) Links B Cell Receptor Signaling to the Activation of Hematopoietic Progenitor Kinase 1
J. Exp. Med., August 20, 2001; 194(4): 529 - 540.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
N. J. Boerth, J. J. Sadler, D. E. Bauer, J. L. Clements, S. M. Gheith, and G. A. Koretzky
Recruitment of Slp-76 to the Membrane and Glycolipid-Enriched Membrane Microdomains Replaces the Requirement for Linker for Activation of T Cells in T Cell Receptor Signaling
J. Exp. Med., October 2, 2000; 192(7): 1047 - 1058.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Moog-Lutz, E. J. Peterson, P. G. Lutz, S. Eliason, F. Cave-Riant, A. Singer, Y. Di Gioia, S. Dmowski, J. Kamens, Y. E. Cayre, et al.
PRAM-1 Is a Novel Adaptor Protein Regulated by Retinoic Acid (RA) and Promyelocytic Leukemia (PML)-RA Receptor alpha in Acute Promyelocytic Leukemia Cells
J. Biol. Chem., June 15, 2001; 276(25): 22375 - 22381.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Sauer, J. Liou, S. B. Singh, D. Yablonski, A. Weiss, and R. M. Perlmutter
Hematopoietic Progenitor Kinase 1 Associates Physically and Functionally with the Adaptor Proteins B Cell Linker Protein and SLP-76 in Lymphocytes
J. Biol. Chem., November 21, 2001; 276(48): 45207 - 45216.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Geng, S. Pfister, S.-K. Kraeft, and C. E. Rudd
Adaptor FYB (Fyn-binding protein) regulates integrin-mediated adhesion and mediator release: Differential involvement of the FYB SH3 domain
PNAS, September 25, 2001; 98(20): 11527 - 11532.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geng, L.
Right arrow Articles by Rudd, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geng, L.
Right arrow Articles by Rudd, C. E.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS